BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coffin CS, Fung SK, Alvarez F, Cooper CL, Doucette KE, Fournier C, Kelly E, Ko HH, Ma MM, Martin SR, Osiowy C, Ramji A, Tam E, Villeneuve JP. Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. CanLivJ 2018;1:156-217. [DOI: 10.3138/canlivj.2018-0008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Farag MS, Fung S, Tam E, Doucette K, Wong A, Ramji A, Conway B, Cooper C, Tsoi K, Wong P, Sebastiani G, Brahmania M, Haylock-Jacobs S, Coffin CS, Hansen BE, Janssen HLA. Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study. J Viral Hepat 2021;28:942-50. [PMID: 33749086 DOI: 10.1111/jvh.13500] [Reference Citation Analysis]
2 Remington TL, Osman M, Simmonds K, Charlton C, Doucette K. Baseline assessment of and linkage to care for newly diagnosed patients with chronic hepatitis B. CanLivJ 2020;3:263-75. [DOI: 10.3138/canlivj.2019-0024] [Reference Citation Analysis]
3 Htet NH, Naing C, Vongpunsawad S, Win TT, Poovorawan Y; Cochrane Hepato-Biliary Group. Thymosin-ɑ1 for people with chronic hepatitis B. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd014610] [Reference Citation Analysis]
4 Tian F, Feld JJ, Feng Z, Sander B, Wong WWL. Feasibility of hepatitis B elimination in high-income countries with ongoing immigration. J Hepatol 2022:S0168-8278(22)00249-5. [PMID: 35483535 DOI: 10.1016/j.jhep.2022.04.014] [Reference Citation Analysis]
5 Lun Yau AH, Galorport C, Coffin CS, Ko HH. Hepatocellular carcinoma screening practices among patients with chronic hepatitis B by Canadian gastroenterologists and hepatologists: An online survey. CanLivJ 2019;2:199-209. [DOI: 10.3138/canlivj.2019-0012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Dilokthornsakul P, Sawangjit R, Tangkijvanich P, Chayanupatkul M, Tanwandee T, Sukeepaisarnjaroen W, Sriuttha P, Permsuwan U. Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand. Appl Health Econ Health Policy 2022. [PMID: 35141850 DOI: 10.1007/s40258-022-00719-y] [Reference Citation Analysis]
7 Amirzade-iranaq MH, Hatami M, Khosravi MH, Alavian SM. Hepatitis B Vaccination Status in Dental Practitioners: Local Horrifying Report, National Considerable Issue, and Global Health Impact. Hepat Mon 2021;20. [DOI: 10.5812/hepatmon.100242] [Reference Citation Analysis]
8 Chahal D, Lee JG, Yoshida EM, Lowe C, Ho F, Sum V, Kwan P. Seroprevalence of hepatitis B in previously undiagnosed patients: A community screening study. CanLivJ. [DOI: 10.3138/canlivj-2021-0008] [Reference Citation Analysis]
9 Binka M, Butt ZA, McKee G, Darvishian M, Cook D, Wong S, Yu A, Alvarez M, Samji H, Wong J, Krajden M, Janjua NZ. Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada. Int J Infect Dis 2021;106:246-53. [PMID: 33771673 DOI: 10.1016/j.ijid.2021.03.061] [Reference Citation Analysis]
10 Lai MW, Chang MH. Updates in the management of hepatitis B in children. Expert Rev Gastroenterol Hepatol 2019;13:1065-76. [PMID: 31663387 DOI: 10.1080/17474124.2019.1686975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
11 Shapiro H, Zaman L, Kennedy VL, Dean N, Yudin MH, Loutfy M. Managing and preventing blood-borne viral infection transmission in assisted reproduction: a Canadian Fertility and Andrology Society clinical practice guideline. Reprod Biomed Online 2020;41:203-16. [PMID: 32546334 DOI: 10.1016/j.rbmo.2020.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cooper C, Driedger M, Wong D, Haylock-Jacobs S, Aziz Shaheen A, Osiowy C, Fung S, Doucette K, Wong A, Barrett L, Conway B, Ramji A, Minuk G, Sebastiani G, Wong P, Coffin CS. Distinct Hepatitis B and HIV co-infected populations in Canada. J Viral Hepat 2021;28:517-27. [PMID: 33306853 DOI: 10.1111/jvh.13453] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tout I, Loureiro D, Asselah T. The Changing Demographics of Hepatitis B Virus Infection. Clin Liver Dis 2021;25:673-87. [PMID: 34593147 DOI: 10.1016/j.cld.2021.06.001] [Reference Citation Analysis]
14 Osiowy C, Swidinsky K, Haylock-jacobs S, Sadler MD, Fung S, Wong D, Minuk GY, Doucette KE, Wong P, Tam E, Cooper C, Ramji A, Ma M, Nudo C, Tsoi K, Coffin CS. Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100461] [Reference Citation Analysis]